Brave Asset Management’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Brave Asset Management’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-49	Closed	–	–	370
2016 Q3	$0	Hold	49	–	–	﹤0.01%	412
2016 Q2	$0	Hold	49	–	–	﹤0.01%	440
2016 Q1	$0	Hold	49	–	–	﹤0.01%	435
2015 Q4	$0	Hold	49	–	–	﹤0.01%	445
2015 Q3	$0	Sell	49 -529	-92%	-$479	﹤0.01%	444
2015 Q2	$1K	Hold	578	–	–	﹤0.01%	428
2015 Q1	$1K	Hold	578	–	–	﹤0.01%	423
2014 Q4	$1K	Buy	+578	New	+$627	﹤0.01%	426

Other funds holding BTX.WS

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Brave Asset Management's BTX.WS Position: Q4 2016 in Review

Brave Asset Management sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q4 2016, closing a stake of 49 shares.

Brave Asset Management first reported a position in BTX.WS in Q4 2014 and held it in 8 quarters. The position peaked at $1K in Q2 2015. 35 funds tracked by Wall St. Rank hold BTX.WS as of Q4 2016.

Brave Asset Management reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q4 2016 after selling out during the quarter.
Brave Asset Management sold 49 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q4 2016.
Brave Asset Management first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2014 and held it in 8 quarters.
Brave Asset Management's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $1K in Q2 2015.
35 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q4 2016.

Based on Brave Asset Management's 13F filing for Q4 2016, filed 27 Jan 2017.